Are you the parent or guardian of a preschool-age (4–5 years old) child who struggles
with hyperactivity, impulsivity, or inattention? If so, your child may be showing
symptoms of Attention-Deficit Hyperactivity Disorder (ADHD). A study medication approved
by the FDA for children 6 years and older is now being evaluated for younger
children
A Clinical Study for Preschoolers
with ADHD Symptoms
This clinical study is evaluating an FDA-approved medication for ADHD — currently used in
children ages 6 and older — to better understand how it works in preschool-age children
(ages 4–5).
This study is approximately 10 weeks in duration (8 Study Visits). If after Visit 1 (Screening) and Visit 2 (Baseline) your child is found to be eligible to take the study drug, he/she will need to come to the study center for 6 additional visits (Visits 3-8; 6 weeks).
Why this study?
No-Cost, Study-Related Care
Your child may receive study-related medical care and the investigational medication at no
cost, plus compensation for time and travel.
Expert Oversight & Structured
Visits
Families follow a clear plan (up to 10 weeks, 8 in-person visits and 1 phone call), with
careful monitoring from experienced study staff.
Help Advance Preschool ADHD Care
Your participation helps researchers evaluate an FDA-approved ADHD medication for younger
children and improve future treatment options.
How Participation Works
Step 1
Connect with a Study Site
If you are interested in learning more about the study or think your child may be eligible, please reach out to the study site closest to you by clicking on the Find a Study Site Near You tab below.
If your child is eligible to take part in this study, their participation is expected to last up to 10 weeks [includes a Screening Period up to 4 weeks and a Study Treatment Period that is 6 weeks].